Evolocumab

Common brands: Repatha, Aspirin 325, Aspirin 81, Ecotrin, Low Dose Aspirin

Top reporter: Amgen Usa Inc.

PCSK9 Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]Dietary Cholesterol Absorption Inhibitor [EPC]Provitamin D2 Compound [EPC]
157,026
Total Reports
76,690
Serious Reports
1,902
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.21%)

Patient Demographics

Male
60,610
Female
84,636

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Evolocumab.

# Reaction Reports % of Total
1 DEVICE DIFFICULT TO USE 32,601
16.7%
2 DRUG DOSE OMISSION BY DEVICE 24,421
12.5%
3 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22,053
11.3%
4 ACCIDENTAL EXPOSURE TO PRODUCT 16,450
8.4%
5 INJECTION SITE PAIN 10,546
5.4%
6 PRODUCT STORAGE ERROR 6,647
3.4%
7 BACK PAIN 5,497
2.8%
8 MYALGIA 5,332
2.7%
9 DRUG DOSE OMISSION 4,929
2.5%
10 INJECTION SITE BRUISING 4,632
2.4%
11 DEVICE USE ERROR 4,119
2.1%
12 ARTHRALGIA 3,979
2.0%
13 FATIGUE 3,927
2.0%
14 INJECTION SITE HAEMORRHAGE 3,893
2.0%
15 OFF LABEL USE 3,865
2.0%
16 RHINORRHOEA 3,566
1.8%
17 PAIN IN EXTREMITY 3,416
1.7%
18 MUSCLE SPASMS 3,209
1.6%
19 INFLUENZA LIKE ILLNESS 3,142
1.6%
20 PAIN 3,025
1.5%
21 HEADACHE 2,954
1.5%
22 INCORRECT DOSE ADMINISTERED BY DEVICE 2,945
1.5%
23 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2,875
1.5%
24 PRODUCT PREPARATION ERROR 2,829
1.4%
25 NASOPHARYNGITIS 2,539
1.3%
26 INTERCEPTED PRODUCT ADMINISTRATION ERROR 2,517
1.3%
27 PRODUCT COMMUNICATION ISSUE 2,511
1.3%
28 DIARRHOEA 2,505
1.3%
29 NAUSEA 2,435
1.2%
30 DIZZINESS 2,402
1.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.